Company · CIK 1807901
Pandion Therapeutics, Inc.
| CIK | 1807901 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-08-31 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-239500 | 2020-06-26 | 2021-04-05 | 6 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-04-05 | EFFECTDeclared effective | 333-239894 | 9999999995-21-001275 |
| 2021-04-05 | EFFECTDeclared effective | 333-239500 | 9999999995-21-001274 |
| 2020-07-17 | 424B4Final prospectus | 333-239500 | 0001193125-20-194428 |
| 2020-07-16 | EFFECTDeclared effective | 333-239500 | 9999999995-20-001830 |
| 2020-07-16 | S-1/AAmendment | 333-239500 | 0001193125-20-193645 |
| 2020-07-13 | S-1/AAmendment | 333-239500 | 0001193125-20-191430 |
| 2020-06-26 | S-1Registration filed | 333-239500 | 0001193125-20-181101 |
| 2020-05-22 | DRSDraft made public | 377-03182 | 0000950123-20-005489 |